glaxosmithkline plc-spon adr
(GS7A:Frankfurt)
Executive Profile*
Moncef M. Slaoui Ph.D.Chairman of Global R&D & Vaccines, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee, GlaxoSmithKline plc |
| Age | Total Calculated Compensation | This person is connected to 34 board members in 3 different organizations across 3 different industries. See Board Relationships |
| 52 | $4,610,000 As of Fiscal Year 2012 |
Background*
Dr. Moncef M. Slaoui, Ph.D., serves as the Chairman of Research & Development at Glaxosmithkline Biologicals S.A. Dr. Slaoui serves as Chairman of Global R&D & Vaccines at GlaxoSmithKline PLC. Dr. Slaoui serves as a Member of the Corporate Executive Team of GlaxoSmithKline, PLC. He served as the Chairman of Research and Development at GlaxoSmithKline PLC since June 1, 2006 and leads the complex drug discovery and development activities. He served as Senior Vice President ...
Corporate Headquarters*980 Great West RoadBrentford, Middlesex TW8 9GS United Kingdom Phone: 44 20 8047 5000 Fax: 44 20 8047 7807 Board Members Memberships*Former Director Director and Member of Strategic Advisory Board 2006-Present Chairman of Global R&D & Vaccines, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
Education*PhD Universite Libre de Bruxelles in Belgium
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| GS7A:GR | €40.25 EUR | +0.53 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| John C. Martin Ph.D. | Chairman and Chief Executive Officer Gilead Sciences Inc. | $1.5M |
| Marijn E. Dekkers Ph.D. | Chairman of Management Board and Chief Executive Officer Bayer AG | €3.0M |
| Kenneth C. Frazier | Chairman, Chief Executive Officer and President Merck & Co. Inc. | $1.5M |
| Christopher A. Viehbacher | Chief Executive Officer, Director and Member of Strategy Committee Sanofi | €3.5M |
| Severin Schwan | Chief Executive Officer and Director Roche Holding AG | SFr.6.5M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: May 20
Sponsored Financial Commentaries
Sponsored Links
To contact GLAXOSMITHKLINE PLC-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
